DEK::AFF2 rearranged neoplasm with undifferentiated morphology and neuroendocrine phenotype in a pediatric patient
- PMID: 40119902
- DOI: 10.1007/s00428-025-04071-z
DEK::AFF2 rearranged neoplasm with undifferentiated morphology and neuroendocrine phenotype in a pediatric patient
Abstract
The advent of next-generation sequencing (NGS) has greatly enhanced the identification of morphologically and/or phenotypically unusual neoplasms. We report an undifferentiated carcinoma with a DEK::AFF2 fusion in a 13-year-old female from the head and neck region. DEK::AFF2 rearranged non-keratinizing squamous cell carcinoma (NKSCC) has been recognized as a distinct entity in the WHO classification of head and neck tumors, typically affecting adults. The case presented is unusual for both the patient's age and the undifferentiated morphology, which includes neuroendocrine immunophenotypic features, such as focal synaptophysin staining, dot-like cytokeratin expression, and only scattered cells positive for p63 and p40. Additional cases are needed to determine whether these features define a distinct subset of DEK::AFF2 rearranged neoplasms and to assess their potential correlation with a younger age of occurrence.
Keywords: DEK:AFF2 rearranged; Head and neck carcinoma; Neuroendocrine; Pediatric; Squamous carcinoma; Undifferentiated neoplasm.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Ethics approval: Ethical approval is not required as this is a case report. All the clinical and pathologic investigations detailed in the manuscript have been conducted in accordance with the Declaration of Helsinki and its later amendments. Competing interests: The authors declare no competing interests. Patient consent statement: Informed consent for publication of data and images was obtained from the parents as the subject of the report is a minor. Permission to reproduce materials from other sources: No materials from other sources is reproduced within the submitted article. Clinical trial registration: Not applicable.
References
-
- Rooper LM, Agaimy A, Dickson BC, Dueber JC, Eberhart CG, Gagan J, Hartmann A, Khararjian A, London NR, MacMillan CM, Palsgrove DN, Nix JS, Sandison A, Stoehr R, Truong T, Weinreb I, Bishop JA (2021) DEK-AFF2 carcinoma of the sinonasal region and skull base: detailed clinicopathologic characterization of a distinctive entity. Am J Surg Pathol 45(12):1682–1693. https://doi.org/10.1097/PAS.0000000000001741 - DOI - PubMed
-
- Trinquet A, Laé M, Lépine C, Lanic MD, Lacheretz-Szablewski V, Shaar Chneker C, Goujon JM, Favier V, Costes-Martineau V (2024) Sinonasal squamous cell carcinoma with DEK::AFF2 rearrangement: an aggressive cancer with bland morphology. Am J Surg Pathol. https://doi.org/10.1097/PAS.0000000000002281
-
- Amin SE, Lewis JS Jr, Bridge JA, Hang JF, Naik U, Bishop JA, Saluja K (2024) DEK::AFF2 fusion-associated squamous cell carcinoma: a case series with literature review on an emerging and challenging entity. Head Neck Pathol 18(1):86. https://doi.org/10.1007/s12105-024-01690-x.PMID:39312022;PMCID:PMC11420419 - DOI - PubMed
-
- Agarwal A, Bhatt AA, Bathla G, Kanekar S, Soni N, Murray J, Vijay K, Vibhute P, Rhyner PH (2023) Update from the 5th edition of the WHO classification of nasal, paranasal, and skull base tumors: imaging overview with histopathologic and genetic correlation. AJNR Am J Neuroradiol. 44(10):1116–1125. https://doi.org/10.3174/ajnr.A7960 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
